Search results for "Age-related macular degeneration"

showing 10 items of 25 documents

PHOTODYNAMIC THERAPY WITH VERTEPORFIN FOR CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH RETINAL PIGMENT EPITHELIAL DETACHMENT IN AGE-RELATED MACULAR D…

2007

Abstract PURPOSE: To assess the effectiveness of photodynamic therapy (PDT) with verteporfin for choroidal neovascularization (CNV) associated with retinal pigment epithelium detachment (PED) in age-related macular degeneration. METHODS: Thirty eyes of 26 patients with CNV and PED were treated with PDT. The eyes were divided in two groups based on CNV location in relation to PED; group 1 included 13 eyes with CNV within PED, and group 2 included 17 eyes with CNV at the edge of PED. The median follow-up was 16 months. RESULTS: Patients received a mean +/- SD of 2.83 +/- 1.26 treatments (range, 1-6 treatments). In the whole cohort, the mean preoperative visual acuity changed from 20/144 (0.86…

Malemedicine.medical_specialtyPorphyrinsVisual acuitygenetic structuresmedicine.medical_treatmentVisual AcuityPhotodynamic therapyMacular DegenerationAge relatedOphthalmologymedicineHumansProspective StudiesFluorescein AngiographyPigment Epithelium of EyeAgedAged 80 and overPhotosensitizing AgentsRetinal pigment epitheliumSettore MED/30 - Malattie Apparato Visivobusiness.industryRetinal DetachmentVerteporfinGeneral MedicineMiddle AgedMacular degenerationmedicine.diseaseVerteporfinChoroidal Neovascularizationeye diseasesOphthalmologyTreatment Outcomemedicine.anatomical_structureChoroidal neovascularizationPhotochemotherapyFemaleRetinal pigment epithelial detachmentsense organsPhotodynamic therapy choroidal neovascularization age-related macular degenerationmedicine.symptombusinessFollow-Up Studiesmedicine.drugRetina
researchProduct

Geo-Epidemiology of Age-Related Macular Degeneration: New Clues Into the Pathogenesis

2015

Abstract PURPOSE: To evaluate the demographic, geographic, and race-related variables that account for geographic variability in prevalence rates of age-related macular degeneration (AMD). DESIGN: Systematic review, meta-regression, and decision-tree analysis. METHODS: A systematic literature review of PubMed, Medline, Web of Science, and Embase databases identified population-based studies on the prevalence of AMD published before May 2014. Only population-based studies that took place in a spatially explicit geographic area that could be geolocalized, and used retinal photographs and standardized grading classifications, were included. Latitude and longitude data (geolocalization) and the…

Malemedicine.medical_specialtygenetic structuresPopulationPrevalenceGlobal HealthPrevalence of AMDLatitude03 medical and health sciencesMacular Degeneration0302 clinical medicineAge DistributionRisk FactorsEpidemiologymedicinePrevalenceHumans030212 general & internal medicineSex DistributioneducationAgedAged 80 and overeducation.field_of_studyGeoepidemiologyGeographySettore MED/30 - Malattie Apparato VisivoDecision TreesRegression analysisBayes TheoremMiddle Agedeye diseasesOphthalmologyGeographySystematic reviewAge-Related Macular DegenerationMeta-analysis030221 ophthalmology & optometryFemalesense organsLongitudeDemography
researchProduct

Evidence of neuroplasticity in the human visual cortex following beneficial anti-VEGF treatment in exudative age-related macular degeneration

2012

Purpose Anti-vascular endothelial growth factor (VEGF) agents have been shown to improve visual acuity and prevent vision loss in exudative age-related macular degeneration (AMD). As the vision improves relatively quickly in response to intravitreal injections, we wanted to know whether this improvement is reflected in electrophysiolocal markers of visual cortical processing. Methods Our interventional case series included 6 elderly patients who underwent injection treatment to the affected eye. Their visual acuity, tomographic images of retinal thickness and visual evoked potentials (VEP) were assessed before of the treatment and six weeks after the last injection. Results All patients sho…

Retinamedicine.medical_specialtyVisual acuitygenetic structuresbusiness.industryRetinalGeneral MedicineMacular degenerationAudiologymedicine.diseaseExudative age-related macular degenerationeye diseasesOphthalmologychemistry.chemical_compoundmedicine.anatomical_structureVisual cortexchemistryOphthalmologyNeuroplasticityMedicinesense organsAnti vegf treatmentmedicine.symptombusinessActa Ophthalmologica
researchProduct

Towards the new spectral-domain optical coherence tomography based classification of age-related macular degeneration

2012

Introducción: La degeneración macular asociada a la edad (DMAE) es un problema sociosanitario de primer orden en las sociedades industrializadas. La aportación de las nuevas técnicas diagnósticas, fundamentalmente la tomografía de coherencia óptica de dominio espectral (SD-OCT), ha ayudado a comprender mejor esta enfermedad. Objetivo: Recordar la clasificación clínica vigente de la DMAE, exponer la nueva clasificación tomográfica de la DMAE exudativa, y revisar los nuevos nuevos hallazgos tomográficos de la degeneración macular seca. Desarrollo: Clásicamente se distinguen dos formas de DMAE: seca y exudativa; asimismo existen tres estadios progresivos de severidad: precoz, intermedio y tard…

Tomografía de coherencia ópticaDrusenOptical coherence tomographyDegeneración macular asociada a la edadAge-related macular degenerationSubretinal drusenoid depositsNeovascularización coroideaDrusasChoroidal neovascularisationDepósitos drusenoides subretinianos
researchProduct

Treat and extend versus fixed regimen in neovascular age related macular degeneration: A systematic review and meta-analysis

2020

Purpose: To compare efficacy of treat and extend (T&E) versus fixed regimen treatment protocols in neovascular age-related macular degeneration (nAMD). Methods: Randomized clinical trials (RCTs) comparing T&E versus fixed regimen protocols for nAMD were systematically searched. Primary outcome was to compare the mean best corrected visual acuity (BCVA) change in T&E regimen versus fixed regimen. Secondary outcomes were change in the mean optical coherence tomography (OCT) central retinal thickness (CRT) and mean number of injections. Standardized mean difference (SMD) along with 95% confidence intervals (CIs) were calculated. Random-effect models were used for meta-analyses. Res…

Vascular Endothelial Growth Factor Amedicine.medical_specialtyretinaretinal pathology/researchVisual AcuityAngiogenesis InhibitorsTreat and extendlaw.inventionMacular DegenerationRandomized controlled trialClinical Protocolsretina – medical therapieslawInternal medicineAge relatedRanibizumabMedicineHumansbusiness.industryAge-related macular degenerationGeneral MedicineMacular degenerationpediatric ophthalmologyretina – medical therapiemedicine.diseaseOphthalmologyRegimenTreatment OutcomeMeta-analysisvitreous/retinal diseaseIntravitreal InjectionsWet Macular DegenerationPediatric ophthalmologypharmacologybusinessTomography Optical CoherenceAge-related macular degeneration; pediatric ophthalmology; pharmacology; retina; retina – medical therapies; retinal pathology/research; vitreous/retinal disease
researchProduct

Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections

2022

Background and Objectives: Brolucizumab is a novel anti-vascular endothelial growth factor (VEGF), whose efficacy has been shown in the Hawk and Harrier phase 3 clinical studies. The goal of the present case series is to report initial results of brolucizumab intravitreal injections (IVI) on type 3 neovascularization in neovascular age-related macular degeneration (nAMD), evaluated by optical coherence tomography angiography (OCTA). Materials and Methods: This is a bicentric retrospective case series. Patients with newly diagnosed type 3 MNV treated with brolucizumab IVI and at least 6 months follow-up were enrolled. OCTA en face images and B-scans were analyzed for lesions at baseline, 1 m…

Vascular Endothelial Growth Factor Atype 3 neovascularization.brolucizumabNeovascularization PathologicVisual Acuityneovascular age-related macular degeneration; type 3 neovascularization; retinal angiomatous proliferation; brolucizumab; optical coherence tomography angiography; intravitreal injectionintravitreal injectionretinal angiomatous proliferationEndothelial Growth Factorsneovascular age-related macular degenerationGeneral MedicineAntibodies Monoclonal Humanizedoptical coherence tomography angiographyIntravitreal InjectionsHumansFluorescein AngiographyTomography Optical CoherenceRetrospective StudiesMedicina
researchProduct

Proteomic analysis of sub-retinal deposits in age-related macular degeneration

2014

National audience

[SDE] Environmental Sciencesretina[SPI.GPROC] Engineering Sciences [physics]/Chemical and Process Engineering[SDV]Life Sciences [q-bio]aging[SDV.IDA] Life Sciences [q-bio]/Food engineering[SDV] Life Sciences [q-bio][SDE]Environmental Sciences[SDV.IDA]Life Sciences [q-bio]/Food engineering[SDV.BV]Life Sciences [q-bio]/Vegetal Biology[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process Engineering[SDV.BV] Life Sciences [q-bio]/Vegetal Biologylaser dissection microscopeage-related macular degenerationComputingMilieux_MISCELLANEOUS
researchProduct

Cholestérol-24S-hydroxylase (CYP46A1) et homéostasie du cholestérol dans la rétine en conditions physiologiques et pathologiques

2012

Cholesterol is the major sterol found in the retina. In its free form, cholesterol is present in all cell layers of the retina, whereas cholesteryl esters mainly accumulate at the basement of the retinal pigment epithelium. The intrinsic capacity of the retina to synthetize cholesterol appears limited. Some extra-retinal pathways actively participate to cholesterol uptake to the retina. Müller glial cells may contribute to cholesterol supply to retinal neurons, especially for synaptic formation. Cholesterol accumulation or conversely deficiency have deleterious consequences on neuron survival. Maintaining the equilibrium between cholesterol supply and neosynthesis in the one hand and choles…

[SDV.SA]Life Sciences [q-bio]/Agricultural sciencesRétinePolymorphisme génétique24S-HYDROXYCHOLESTÉROLRetinaCHOLESTÉROL-24S-HYDROXYLASE24S-hydroxycholesterolMétabolisme[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyGliaPathologyGlieCholesterol-24S-hydroxylase[ SDV.SA ] Life Sciences [q-bio]/Agricultural sciences[SDV.SA] Life Sciences [q-bio]/Agricultural sciencesPathologie[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyDégénérescence maculaire liée à l’âgeCHOLESTEROLAge-related macular degenerationGene polymorphismGlaucomaNeuronGlaucome[SDV.AEN] Life Sciences [q-bio]/Food and NutritionCYP46A1MetabolismCholestérol[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyNeurone
researchProduct

Algorithms for the Automated Analysis of Age-Related Macular Degeneration Biomarkers on Optical Coherence Tomography: A Systematic Review

2017

PURPOSE To assess the quality of optical coherence tomography (OCT) grading algorithms for retinal biomarkers of age-related macular degeneration (AMD). METHODS Following a systematic review of the literature data on detection and quantification of AMD retinal biomarkers by available algorithms were extracted and descriptively synthesized. Algorithm quality was assessed using a modified version of the Quality Assessment of Diagnostic Accuracy Studies 2 checklist with a focus on accuracy against established reference standards and risk of bias. RESULTS Thirty five studies reporting computer-aided diagnosis (CAD) tools for qualitative analysis or algorithms for quantitative analysis were iden…

automated image analysisBiomedical EngineeringCADReviewDrusen030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineOptical coherence tomographyAge relatedmedicineGrading (tumors)age-related macular degenerationoptical coherence tomographymedicine.diagnostic_testbusiness.industryMacular degenerationmedicine.diseaseeye diseasesOphthalmologySystematic review030221 ophthalmology & optometryBiomarker (medicine)sense organsbusinessAlgorithmTranslational Vision Science & Technology
researchProduct

Body size at birth and age-related macular degeneration in old age

2019

Purpose To study associations between body size at birth and age-related macular degeneration (AMD) in old age. Methods The study sample consists of 1497 community-dwelling individuals (56.1% women) aged 67-89 years with birth data and retinal data collected twice in old age 5 years apart. Birth data (weight, length, birth order) were extracted from original birth records. Digital retinal photographs were graded to determine AMD status. Data on covariates were collected at the baseline physical examination in old age. Multivariable regression analyses were used to study the association between birth data and AMD adjusting for known confounding factors, including birth year cohort effects. R…

genetic structuresMACULOPATHYPopulationArticle03 medical and health sciences0302 clinical medicineMedicinesyntymäpainoCORONARY-HEART-DISEASE3125 Otorhinolaryngology ophthalmology10. No inequalityeducationage-related macular degenerationBirth YearPOPULATIONeducation.field_of_studyHYPERTENSIONbusiness.industryIncidence (epidemiology)age‐related macular degenerationGeneral MedicineMacular degenerationbody size at birthmedicine.diseaseObesityeye diseasessilmänpohjan ikärappeumaPREVALENCELIFEOphthalmologyBirth orderCohort effectQuartile030221 ophthalmology & optometrySUBSEQUENT RISKsense organsWEIGHTbusiness030217 neurology & neurosurgeryDemography
researchProduct